Anabolic Steroid Abuse

Total Page:16

File Type:pdf, Size:1020Kb

Load more

NATIONAL INSTITUTE ON DRUG ABUSE Research Report SERIES Persistent reports of anabolic steroid abuse by professional athletes, many of whom are regarded as role models by young people, highlight the fact that we are now facing a very damaging message in our society— that bigger is better, and being the best is more important than how you get there. Abuse of anabolic steroids differs from the abuse of other illicit sub- stances because the initial abuse of anabolic steroids is not driven by the immediate euphoria that accompanies most drugs of abuse, such as cocaine, heroin, and marijuana, but by the What are Anabolic steroids were devel- desire of abusers to change their oped in the late 1930s primarily appearance and performance, characteristics of great importance anabolic steroids? to treat hypogonadism, a condi- to adolescents. The effects of steroids nabolic steroids” is the tion in which the testes do not can boost confidence and strength, “ familiar name for synthetic produce sufficient testosterone leading abusers to overlook the poten- tial serious and long-term damage Asubstances related to the for normal growth, development, that these substances can cause. male sex hormones (e.g., testos- and sexual functioning. The r While anabolic steroids can terone). They promote the growth primary medical uses of these enhance certain types of performance of skeletal muscle (anabolic compounds are to treat delayed o or appearance, they are dangerous drugs, and when used inappropriately effects) and the development puberty, some types of impo- t they can cause a host of severe, of male sexual characteristics tence, and wasting of the body long-lasting, and in some cases, c irreversible negative health conse- (androgenic effects) in both males caused by HIV infection or other quences. Anabolic steroids can lead and females. The term “anabolic diseases. to early heart attacks, strokes, liver e steroids” will be used through- During the 1930s, scientists tumors, kidney failure, and serious out this report because of its discovered that anabolic steroids r psychiatric problems. In addition, familiarity, although the proper could facilitate the growth of i because steroids are often injected, users who share needles or use non- term for these compounds is skeletal muscle in laboratory sterile techniques when they inject “anabolic-androgenic steroids.” animals, which led to abuse of d steroids are at risk for contracting dangerous infections, such as HIV/AIDS and hepatitis B and C. I hope that students, parents, 12th-Graders’ Perceived Harmfulness of Steroid Use e teachers, coaches, and others will take advantage of the information 80% about anabolic steroids found on h the NIDA Web site (www.steroid- 68.1% t 60 abuse.gov) and join us in our 62.1% prevention and education efforts. 57.9% 58.9% 57.1% 55.0% 55.7% 56.8% Participating in sports offers many 40 benefits, but young people and adults should not take unnecessary health m risks in an effort to win. 20 Nora D.Volkow,M.D. o 0 Director 1998 1999 2000 2001 2002 2003 2004 2005 r National Institute on Drug Abuse Source: 2005 Monitoring the Future Survey. f U.S. Department of Health and Human Services • National Institutes of Health 2NIDA RESEARCH REPORT SERIES the compounds first by body- builders and weightlifters and What is the scope Why do people then by athletes in other sports. of steroid use in abuse anabolic Steroid abuse has become so widespread in athletics that it the United States? steroids? can affect the outcome of sports he 2005 Monitoring the ne of the main reasons contests. Future study, a NIDA-funded people give for abusing Illicit steroids are often sold at Tsurvey of drug use among steroids is to improve their adolescents in middle and high O gyms, competitions, and through athletic performance. Among mail order operations after being schools across the United States, athletes, steroid abuse has been smuggled into this country. Most reported that past year use of estimated to be less that 6 per- illegal steroids in the United States steroids decreased significantly cent according to surveys, but are smuggled from countries that among 8th- and 10th-graders anecdotal information suggests do not require a prescription for since peak use in 2000. Among more widespread abuse. the purchase of steroids. Steroids 12th-graders, there was a differ- Although testing procedures are are also illegally diverted from ent trend—from 2000 to 2004, now in place to deter steroid U.S. pharmacies or synthesized in past year steroid use increased, abuse among professional and but in 2005 there was a signifi- clandestine laboratories. Olympic athletes, new designer cant decrease, from 2.5 percent drugs constantly become avail- to 1.5 percent. Steroid abuse affects individu- able that can escape detection What are steroidal als of various ages. However, it and put athletes willing to cheat supplements? is difficult to estimate the true one step ahead of testing efforts. This dynamic, however, may n the United States, supple- prevalence of steroid abuse in be about to shift if the saving ments such as tetrahydro- the United States because many of urine and blood samples gestrinone (THG) and data sources that measure drug I abuse do not include steroids. for retesting at a future date androstenedione (street name becomes the standard. The high “Andro”) previously could be Scientific evidence indicates that anabolic steroid abuse among probability of eventual detection purchased legally without a athletes may range between one of the newer designer steroids, prescription through many and six percent. once the technology becomes commercial sources, including health food stores. Steroidal supplements can be converted Commonly Abused Steroids into testosterone or a similar compound in the body. Less is known about the side effects of Oral Steroids Injectable Steroids steroidal supplements, but if I Anadrol I Deca-Durabolin large quantities of these com- (oxymetholone) (nandrolone decanoate) pounds substantially increase I I Durabolin testosterone levels in the body, Oxandrin (nandrolone phenpropionate) then they also are likely to pro- (oxandrolone) I duce the same side effects as I Dianabol Depo-Testosterone anabolic steroids themselves. The (methandrostenolone) (testosterone cypionate) purchase of these supplements, I Equipoise with the notable exception of I Winstrol (boldenone undecylenate) dehydroepiandrosterone (DHEA), (stanozolol) became illegal after the passage I Tetrahydrogestrinone (THG) in 2004 of amendments to the Controlled Substances Act. NIDA RESEARCH REPORT SERIES 3 Annual Prevalence of Steroid Use Among Males Cycling, stacking, and pyramiding Grades 8, 10, 12 Steroids are often abused in 3.5% patterns called “cycling,” which 3.0 involve taking multiple doses of 2.5 steroids over a specific period of time, stopping for a period, 2.0 and starting again. Users also fre- 1.5 quently combine several different 1.0 types of steroids in a process 0.5 known as “stacking.” Steroid 0.0 abusers typically “stack” the 8th Grade 10th Grade 12th Grade drugs, meaning that they take Source: 2005 Monitoring the Future Survey. two or more different anabolic steroids, mixing oral and/or available, plus the fear of who had been raped reported injectable types, and sometimes retroactive sanctions, should give that they markedly increased even including compounds that athletes pause. their bodybuilding activities are designed for veterinary use. Another reason people give after the attack. They believed Abusers think that the different for taking steroids is to increase that being bigger and stronger steroids interact to produce an their muscle size or to reduce would discourage further attacks effect on muscle size that is their body fat. This group because men would find them greater than the effects of each either intimidating or unattractive. includes people suffering from drug individually, a theory that Finally, some adolescents the behavioral syndrome called has not been tested scientifically. abuse steroids as part of a pattern muscle dysmorphia, which causes Another mode of steroid abuse them to have a distorted image of high-risk behaviors. These is referred to as “pyramiding.” of their bodies. Men with muscle adolescents also take risks such This is a process in which users dysmorphia think that they look as drinking and driving, carrying slowly escalate steroid abuse small and weak, even if they are a gun, driving a motorcycle with- (increasing the number of ste- large and muscular. Similarly, out a helmet, and abusing other roids or the dose and frequency women with this condition think illicit drugs. Conditions such as that they look fat and flabby, muscle dysmorphia, a history of of one or more steroids used at even though they are actually physical or sexual abuse, or a one time), reaching a peak lean and muscular. history of engaging in high-risk amount at mid-cycle and gradu- Some people who abuse behaviors have all been associat- ally tapering the dose toward the steroids to boost muscle size ed with an increased risk of initi- end of the cycle. Often, steroid have experienced physical or ating or continuing steroid abuse. abusers pyramid their doses in sexual abuse. In one series of cycles of 6 to 12 weeks. At the interviews with male weight- beginning of a cycle, the person lifters, 25 percent who abused How are anabolic starts with low doses of the steroids reported memories of steroids abused? drugs being stacked and then childhood physical or sexual ome anabolic steroids are slowly increases the doses. In abuse. Similarly, female weight- taken orally, others are the second half of the cycle, the lifters who had been raped were injected intramuscularly, doses are slowly decreased to S zero. This is sometimes followed found to be twice as likely to and still others are provided in report use of anabolic steroids gels or creams that are applied to by a second cycle in which the or another purported muscle- the skin.
Recommended publications
  • Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals

    Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals

    Journal of Clinical Medicine Review Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals Carlotta Cocchetti 1, Jiska Ristori 1, Alessia Romani 1, Mario Maggi 2 and Alessandra Daphne Fisher 1,* 1 Andrology, Women’s Endocrinology and Gender Incongruence Unit, Florence University Hospital, 50139 Florence, Italy; [email protected] (C.C); jiska.ristori@unifi.it (J.R.); [email protected] (A.R.) 2 Department of Experimental, Clinical and Biomedical Sciences, Careggi University Hospital, 50139 Florence, Italy; [email protected]fi.it * Correspondence: fi[email protected] Received: 16 April 2020; Accepted: 18 May 2020; Published: 26 May 2020 Abstract: Introduction: To date no standardized hormonal treatment protocols for non-binary transgender individuals have been described in the literature and there is a lack of data regarding their efficacy and safety. Objectives: To suggest possible treatment strategies for non-binary transgender individuals with non-standardized requests and to emphasize the importance of a personalized clinical approach. Methods: A narrative review of pertinent literature on gender-affirming hormonal treatment in transgender persons was performed using PubMed. Results: New hormonal treatment regimens outside those reported in current guidelines should be considered for non-binary transgender individuals, in order to improve psychological well-being and quality of life. In the present review we suggested the use of hormonal and non-hormonal compounds, which—based on their mechanism of action—could be used in these cases depending on clients’ requests. Conclusion: Requests for an individualized hormonal treatment in non-binary transgender individuals represent a future challenge for professionals managing transgender health care. For each case, clinicians should balance the benefits and risks of a personalized non-standardized treatment, actively involving the person in decisions regarding hormonal treatment.
  • Part I Biopharmaceuticals

    Part I Biopharmaceuticals

    1 Part I Biopharmaceuticals Translational Medicine: Molecular Pharmacology and Drug Discovery First Edition. Edited by Robert A. Meyers. © 2018 Wiley-VCH Verlag GmbH & Co. KGaA. Published 2018 by Wiley-VCH Verlag GmbH & Co. KGaA. 3 1 Analogs and Antagonists of Male Sex Hormones Robert W. Brueggemeier The Ohio State University, Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Columbus, Ohio 43210, USA 1Introduction6 2 Historical 6 3 Endogenous Male Sex Hormones 7 3.1 Occurrence and Physiological Roles 7 3.2 Biosynthesis 8 3.3 Absorption and Distribution 12 3.4 Metabolism 13 3.4.1 Reductive Metabolism 14 3.4.2 Oxidative Metabolism 17 3.5 Mechanism of Action 19 4 Synthetic Androgens 24 4.1 Current Drugs on the Market 24 4.2 Therapeutic Uses and Bioassays 25 4.3 Structure–Activity Relationships for Steroidal Androgens 26 4.3.1 Early Modifications 26 4.3.2 Methylated Derivatives 26 4.3.3 Ester Derivatives 27 4.3.4 Halo Derivatives 27 4.3.5 Other Androgen Derivatives 28 4.3.6 Summary of Structure–Activity Relationships of Steroidal Androgens 28 4.4 Nonsteroidal Androgens, Selective Androgen Receptor Modulators (SARMs) 30 4.5 Absorption, Distribution, and Metabolism 31 4.6 Toxicities 32 Translational Medicine: Molecular Pharmacology and Drug Discovery First Edition. Edited by Robert A. Meyers. © 2018 Wiley-VCH Verlag GmbH & Co. KGaA. Published 2018 by Wiley-VCH Verlag GmbH & Co. KGaA. 4 Analogs and Antagonists of Male Sex Hormones 5 Anabolic Agents 32 5.1 Current Drugs on the Market 32 5.2 Therapeutic Uses and Bioassays
  • Anabolic Steroids

    Anabolic Steroids

    epartment .D of .S Ju U s t ic U.S. Department of Justice e . n o Drug Enforcement Administration i t a r t is Office of Diversion Control D in Laws and penalties for anabolic r m ug d E t A steroid abuse (cont’d) nforcemen an individual’s first drug offense. The maximum www.dea.gov penalty for trafficking is five years in prison and a For more information: fine of $250,000 if this is the individual’s first felony drug offense. If this is the second felony drug offense, the maximum period of imprisonment and Please contact your nearest the maximum fine both double. The period of DEA office imprisonment and the amount of fine are enhanced Or if the offense involves the distribution of an anabolic Visit one of our Internet Websites: steroid and a masking agent or if the distribution is to an athlete. In addition, enhanced penalties exist www.DEAdiversion.usdoj.gov for any athletic coach who uses his/her position to Or influence an athlete to use an anabolic steroid. While www.dea.gov the above listed penalties are for federal offenses, individual states have also implemented fines and penalties for illegal use of anabolic steroids. The International Olympic Committee (IOC), National Collegiate Athletic Association (NCAA), and many professional sports leagues (e.g. Major League Baseball, National Basketball Association, National Football League , and National Hockey League) have banned the use of steroids by athletes, both because of their potential dangerous side effects and they give the user an unfair advantage.
  • Adverse Effects of Anabolic-Androgenic Steroids: a Literature Review

    Adverse Effects of Anabolic-Androgenic Steroids: a Literature Review

    healthcare Review Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review Giuseppe Davide Albano 1,†, Francesco Amico 1,†, Giuseppe Cocimano 1, Aldo Liberto 1, Francesca Maglietta 2, Massimiliano Esposito 1, Giuseppe Li Rosi 3, Nunzio Di Nunno 4, Monica Salerno 1,‡ and Angelo Montana 1,*,‡ 1 Legal Medicine, Department of Medical, Surgical and Advanced Technologies, “G.F. Ingrassia”, University of Catania, 95123 Catania, Italy; [email protected] (G.D.A.); [email protected] (F.A.); [email protected] (G.C.); [email protected] (A.L.); [email protected] (M.E.); [email protected] (M.S.) 2 Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy; [email protected] 3 Department of Law, Criminology, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy; [email protected] 4 Department of History, Society and Studies on Humanity, University of Salento, 73100 Lecce, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-095-3782153 † These authors contributed equally to this work. ‡ These authors share last authorship. Abstract: Anabolic-androgenic steroids (AASs) are a large group of molecules including endoge- nously produced androgens, such as testosterone, as well as synthetically manufactured derivatives. AAS use is widespread due to their ability to improve muscle growth for aesthetic purposes and athletes’ performance, minimizing androgenic effects. AAS use is very popular and 1–3% of US inhabitants have been estimated to be AAS users. However, AASs have side effects, involving all organs, tissues and body functions, especially long-term toxicity involving the cardiovascular system Citation: Albano, G.D.; Amico, F.; and the reproductive system, thereby, their abuse is considered a public health issue.
  • 36148 Federal Register / Vol

    36148 Federal Register / Vol

    36148 Federal Register / Vol. 85, No. 115 / Monday, June 15, 2020 / Rules and Regulations Sundstrand) model 54H60 propellers with a collection of information subject to the Administration (NARA). For information on blade having a serial number (S/N) below requirements of the Paperwork Reduction the availability of this material at NARA, S/N 813320. Act unless that collection of information email: [email protected], or go to: displays a currently valid OMB Control https://www.archives.gov/federal-register/cfr/ (d) Subject Number. The OMB Control Number for this ibr-locations.html. Joint Aircraft System Component (JASC) information collection is 2120–0056. Public Issued on June 3, 2020. Code 6111, Propeller Blade Section. reporting for this collection of information is estimated to be approximately 1 hour per Lance T. Gant, (e) Unsafe Condition response, including the time for reviewing Director, Compliance & Airworthiness This AD was prompted by the separation instructions, searching existing data sources, Division, Aircraft Certification Service. of a propeller blade that resulted in the loss gathering and maintaining the data needed, [FR Doc. 2020–12821 Filed 6–12–20; 8:45 am] of an airplane and 17 fatalities. The FAA is completing and reviewing the collection of BILLING CODE 4910–13–P issuing this AD to detect cracking in the information. All responses to this collection propeller blade taper bore. The unsafe of information are mandatory. Send condition, if not addressed, could result in comments regarding this burden estimate or failure of the propeller blade, blade any other aspect of this collection of DEPARTMENT OF JUSTICE separation, and loss of the airplane.
  • The Effects of Hormonal Contraception on the Voice: History of Its Evolution in the Literature

    The Effects of Hormonal Contraception on the Voice: History of Its Evolution in the Literature

    CARE OF THE PROFESSIONAL VOICE Robert T. Sataloff, Associate Editor The Effects of Hormonal Contraception on the Voice: History of its Evolution in the Literature Jennifer Rodney and Robert T. Sataloff [Modified from J. Rodney and R.T. Sataloff, “The Effects of Hormonal Contraception on the Voice: History of its Evolution in the Literature,” Journal of Voice 30, no. 6 (November 2016): 726–730; with permission.] INTRODUCTION: THE MENSTRUAL CYCLE AND THE VOICE The fluctuation of hormones in the menstrual cycle has significant effects on the voice.1 Singing teachers should be familiar with the vocal effects of Jennifer Rodney hormones and of hormonal medications such as oral contraceptives (birth control pills), especially in light of recent changes in their chemistry and effects. Vocal symptoms, known as dysphonia premenstrualis, accompany the better known symptoms of premenstrual syndrome (PMS) during the luteal phase of the menstrual cycle.2 The most common symptoms of dys- phonia premenstrualis are difficulty singing high notes, decreased flexibil- ity, huskiness, fuzziness, breathiness, decreased volume, difficulty bridging passaggios and intonation problems.3 Davis and Davis concluded that, on average, singers experience 33 general symptoms of PMS and 3 symptoms of dysphonia premenstrualis.4 Chae et al. showed that approximately 57% participants met the DSM IV criteria for PMS and also had acoustic evidence Robert T. Sataloff of dysphonia premenstrualis, whereas the PMS-negative group did not.5 The risk of vocal stress and possible damage during the premenstrual period led many European opera houses to offer singers contracts that included “grace days” during their premenstrual period. This accommodation is no longer followed in Europe and was never practiced generally in the United States.6 The mechanisms that cause these symptoms lie not just in the actions of the hormones themselves, but also in the cyclic fluctuation of hormone levels.
  • The Combined Cardiac Effect of the Anabolic Steroid, Nandrolone And

    The Combined Cardiac Effect of the Anabolic Steroid, Nandrolone And

    ù1. v -¿. rlc) 77.- *n*hi.rnool oowol,ù*o ffi"/fu -lo *rn*(o fii'o fio¿o¿¿, /v&"ùún lonno **al cooaiæe';¿vfl"- oã. Benjamin D. Phillis, B.Sc. (Hons) Phatmacology Depattment of Clinical & Experimental Pharmacology Ftome Rd. , Medical School Noth Adelaide Univetsity ADEIAIDE SA 5OOO û.)r.'-*hr/7enveltîù Foremost, I would like to thank my two supervisors for the direction that they have given this ptojecr. To Rod, for his unfailing troubleshooting abiJity and to Jenny fot her advice and ability to add scientific rigour' Many thanks to Michael Adams for his technical assistance and especially fot performing the surgery for the ischaemia-reperfusion projects and for his willingness to work late nights and public holidays. Lastly I would like to thank my v¡ife for her extreme patience during the tumult of the last 5 years. Her love, suppoït, patience and undetstanding have been invaluable in this endeavout. Beniamin D. Phillis Octobet,2005 ADE,I-AIDE ii T*(¿t of Ao,t",tù DECI.ARATION I ACKNOWLEDGEMENTS il TABLE OF CONTENTS UI ABBREVIATIONS x ABSTRACT )ilr CÉIAPTER t-l Inttoduction 1-1 1.1 Background 1,-1, 1.2What ate anabolic stetoids? 7-1 1,3 General pharmacology of Anabolic steroids t-2 '1,-2 1.3.1 Genomic effects of anabolic steroids 1.3.2 Non-genomic effects of anabolic steroids 1-3 1.4 Clinical use of AS 1.-4 1.5 Patterns of AS abuse 1.-4 1.5.1 Steroid abuse by athletes 1.-+ 1.5.2 Stetoid abuse by sedentary teenagers r-6 1.5.3 Prevalence of abuse 1-6 1.5.4 Abuse ptevalence in Australia 1.-9 1.6 Cardiotoxicity of anabolic steroids r-9 1.6.1 Reduced cotonary flow 1.-1.1, 1,.6.2 Dtect myocatdial eff ects 1-1 5 1.6.3 Hypertension 1-21 1.7 Difficulties associated with anabolic steroid research 1.-24 1-25 1.8 The polydrug abuse Phenomenon 1.9 The pharmacology of cocaine 1-26 1.10 Pteparations 1-28 1-29 1.11 Metabolism lll 1-30 1.
  • Effects of Dienogest, a Synthetic Steroid, on Experimental Endometriosis in Rats

    Effects of Dienogest, a Synthetic Steroid, on Experimental Endometriosis in Rats

    European Journal of Endocrinology (1998) 138 216–226 ISSN 0804-4643 Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats Yukio Katsuki, Yukiko Takano, Yoshihiro Futamura, Yasunori Shibutani, Daisuke Aoki1, Yasuhiro Udagawa1 and Shiro Nozawa1 Toxicology Laboratory, Mochida Pharmaceutical Co. Ltd, Fujieda, Shizuoka 426, Japan and 1Department of Obstetrics and Gynecology, School of Medicine, Keio University, Tokyo 160, Japan (Correspondence should be addressed to Y Katsuki, Toxicology Laboratory, Mochida Pharmaceutical Co. Ltd, 342 Gensuke Fujieda, Shizuoka 426, Japan) Abstract Objective: Dienogest, a synthetic steroid with progestational activity, is used as a component of oral contraceptives and is currently being evaluated clinically for the treatment of endometriosis. The present study was conducted to confirm the effects of dienogest on experimental endometriosis in rats and to elucidate its mechanism of action. Design: Experimental endometriosis induced by autotransplantation of endometrium in rats. Methods: Endometrial implants, immune system, and bone mineral were investigated after 3 weeks of medication. Results: Dienogest (0.1–1 mg/kg per day, p.o.) reduced the endometrial implant volume to the same extent as danazol (100 mg/kg per day, p.o.). Simultaneously, dienogest ameliorated the endometrial implant-induced alterations of the immune system; i.e. it increased the natural killer activity of peritoneal fluid cells and splenic cells, decreased the number of peritoneal fluid cells, and decreased interleukin-1b production by peritoneal macrophages. In contrast, danazol (100 mg/kg per day, p.o.) and buserelin (30 mg/kg per day, s.c.) had none of these immunologic effects. Additionally, combined administration of dienogest (0.1 mg/kg per day) plus buserelin (0.3 mg/kg per day) suppressed the bone mineral loss induced by buserelin alone, with no reduction of the effect on endometrial implants.
  • Appendix B Banned Drugs

    Appendix B Banned Drugs

    APPENDIX B BANNED DRUGS (This list complies with 2004-2005 NCAA Bylaw 31.2.3.1 Banned Drugs) A. Stimulants: amiphenazole amphetamine bemigride benzphetamine bromantan caffeine1 (guarana) chlorphentermine cocaine cropropamide crothetamide diethylpropion dimethylamphetamine doxapram ephedrine (ephedra, ma huang) ethamivan ethylamphetamine fencamfamine meclofenoxate methamphetamine methylene-dioxymethamphetamine [MDMA (ecstasy)] methylphenidate nikethamide pemoline pentetrazol phendimetrazine phenmetrazine phentermine phenylephrine phenylpropanolamine (ppa) picrotoxine pipradol prolintane strychnine synephrine (citrus aurantium, zhi shi, bitter orange) and related compounds Approved by Cabinet:1/31/05 Adopted by Board of Trustees:3/18/05 Page 12 of 15 B. Anabolic Agents: polythiazide anabolic steroids quinethazone androstenediol spironolactone androstenedione triamterene boldenone trichlormethiazide clostebol and related compounds dehydrochlormethyltestosterone dehydroepiandrosterone (DHEA) dihydrotestosterone (DHT) D. Street Drugs: dromostanolone heroin fluoxymesterone marijuana3 gestrinone THC mesterolone (tetrahydrocannabinol3 methandienone methenolone methyltestosterone nandrolone norandrostenediol norandrostenedione norethandrolone oxandrolone oxymesterone oxymetholone stanozolol testosterone2 tetrahydrogestrinone (THG) trenbolone and related compounds other anabolic agents clenbuterol C. Diuretics: acetazolamide bendroflumethiazide benzthiazide bumetanide chlorothiazide chlorthalidone ethacrynic acid flumethiazide furosemide hydrochlorothiazide
  • Comparison of Effectiveness Profile of Danazol and Gestrinone in Pelvic Endometriosis: a Community Based Observational Study in Wardha District-Eastern Maharashtra

    Comparison of Effectiveness Profile of Danazol and Gestrinone in Pelvic Endometriosis: a Community Based Observational Study in Wardha District-Eastern Maharashtra

    IOSR Journal Of Pharmacy (e)-ISSN: 2250-3013, (p)-ISSN: 2319-4219 www.iosrphr.org Volume 5, Issue 1 (January 2015), PP. 08-15 Comparison of Effectiveness Profile of Danazol and Gestrinone in Pelvic Endometriosis: A Community Based Observational Study in Wardha District-Eastern Maharashtra Thaim SA*, Jha RK, Saheta A, Santra D, SamaThaim S ABSTRACT: BACKGROUND: Endometriosis is the presence of functioning endometrial tissue outside the uterus and most commonly affects women in the reproductive age group. The present study was conducted to evaluate the effectiveness of Danazol and Gestrinone, steroidal androgenic drugs in the treatment of women with Pelvic Endometriosis in a District of Central India. METHODS: From a period of January 2008 to March 2014 we got 282 women with laparoscopically confirmed diagnosis of Pelvic Endometriosis who were treated with either Danazol or Gestrinone. Out of which 154 were treated with Danazol and 128 were treated with Gestrinone.. Disease severity was measured by calculating the Total symptom severity score using the Biberoglu and Behrman scale at diagnosis and after 90 and 180 days of treatment. Effectiveness was assessed by mean changes in Total symptom severity score after 90 days and 180 days of treatment from the baseline for Danazol and Gestrinone and compared. RESULTS: All demographic and baseline factors were comparable in Danazol and Gestrinone treated groups. Both Danazol and Gestrinone satisfactorily resolved Dysmenorhhoea, Dyspareunia, Pelvic Discomfort, Pelvic Induration and Pelvic Tenderness from baseline. No significant difference were noted in effectiveness endpoints between Danazol and Gestrinone treated groups regarding Total symptom severity score after 90 days and 180 days.
  • Hepatotoxic and Cardiotoxic Effects of Testosterone Enanthate Abuse on Adult Male Albino Rats

    Hepatotoxic and Cardiotoxic Effects of Testosterone Enanthate Abuse on Adult Male Albino Rats

    Al-Azhar Med. J.( Medicine). Vol. 50(2), April, 2021, 1335 - 1348 DOI: 10.12816/amj.2021.158480 https://amj.journals.ekb.eg/article_158480.html HEPATOTOXIC AND CARDIOTOXIC EFFECTS OF TESTOSTERONE ENANTHATE ABUSE ON ADULT MALE ALBINO RATS By Mohamed Abd El-Aziz El-Gendy, Fouad Helmy El-Dabbah, Ashraf Ibrahim Hassan and Naser Abd El-Naby Awad* Departments of Forensic Medicine & Clinical Toxicology and Pathology*, Al-Azhar Faculty of Medicine, Egypt E-mail: [email protected] ABSTRACT Background: Anabolic androgenic steroids (AASs) represent a group of synthetic derivatives of testosterone created to maximize anabolic effects and minimize the androgenic ones. Athletes use anabolic androgenic steroids (AAS) to enhance performance regardless of the health risk they may impact in some persons. Objective: To study the histopathological and biochemical changes that could occur on liver and cardiac muscle after administration of doping dose (supraphysiological dose) of testosterone enanthate (one of AAS). Materials and Methods: One hundred (100) male albino rats were included in the present study and divided into six groups. Group (1a); negative control group, Group (1b) positive control group treated with therapeutic dose of testosterone Enanthate (10 mg /Kg body weight intramuscular / I.M weekly for 12 weeks), group (2) was treated with doping dose of testosterone enanthate (60 mg /Kg body weight/ I.M for 4 weeks), group (3) was treated with treated with doping dose of testosterone enanthate (60 mg /Kg body weight / I.M weekly for 8 weeks), group (4) treated with doping dose of testosterone enanthate (60 mg /Kg body weight / I.M weekly for 12 weeks), group (5a) treated with doping dose of testosterone enanthate (60 mg /Kg body weight/ I.M/ weekly for 12 weeks followed by 2 weeks of treatment discontinuation) , group (5b) treated with doping dose of testosterone enanthate (60 mg /Kg body weight/ I.M weekly for 12 weeks followed by 4 weeks of treatment discontinuation).
  • Detection of Mepitiostane in Doping Analysis

    Detection of Mepitiostane in Doping Analysis

    In: W Schänzer, H Geyer, A Gotzmann, U Mareck (eds.) Recent Advances In Doping Analysis (15). Sport und Buch Strauß - Köln 2007 Masato Okano, Ayako Ikekita, Mitsuhiko Sato, Shinji Kageyama Detection of Mepitiostane in Doping Analysis Anti-doping center, Mitsubishi Chemical Medience Corporation, Tokyo Japan Introduction Hematopoetics, anabolic androgenic steroids used in doping purposes are prohibited by WADA. Table-1 shows most of the clinically used hematopoietics in Japan except for iron preparations 1, our laboratory already has readied analytical methods for EPO and almost anabolic steroids, however, analytical methods have not been conducted for mepitiostane and epitiostanol. Table-1 Hematopoietics used clinically in Japan 1 Commercial name Active compound Epogin, Exprex Erythropoetin alfa Espo, Recomon Erythropoetin beta Aranesp Darbepoetin alfa Hemataide Synthetic peptide Mircera Erythropoietin receptor activator Duran Nandrolone Duramin Nandrolone cyclohexylpropionate Deca Durabolin, Deca Duramin Nandrolone decanoate Durabolin Nandrolone phenylpropionate Mesanolon Mestanolone Primobolan Metenolone Thiodol Epitiostanol Thioderon Mepitiostane (except for sideropenia anemia medicine) Mepitiostane (Thioderon®, 2α, 3α-epithio-17β-(1-methoxycyclopentyloxy)-5α-androstane) -17β-ol), the prodrug of epitiostanol (2α, 3α-epithio-5α-androstane-17β-ol) is an epithiosteroid having anti-estrogenic activity, a concomitant weak androgenic and myotropic activity, and have been used in the treatment of mammary cancer. Mepitiostane and epitiostanol increase hemoglobin in the circulation by stimulating the maturation of CFU-E in 123 In: W Schänzer, H Geyer, A Gotzmann, U Mareck (eds.) Recent Advances In Doping Analysis (15). Sport und Buch Strauß - Köln 2007 the bone marrow. Thioderon® was developed and produced by Shionogi Pharmaceutical Co. Ltd. (Osaka, Japan) 2. Production of Thiodol® was discontinued in 2001, however, Thiodol® has been therapeutically used for the same purposes as Thioderon®.